Aug 28, 2014 at 13:00 | Source: Moneycontrol.com
Sun Pharma and Ranbaxy, which had announced a USD 4-billion deal in April this year, were asked by CCI on Wednesday to make public details of their proposed transaction in a "prescribed format" within 10 working days.
Aug 28, 2014 at 12:19 | Source: PTI
Sun Pharma and Ranbaxy, which had announced a USD 4-billion deal in April this year, were asked late last night to make public details of their proposed transaction in a "prescribed format" within 10 working days.
Aug 28, 2014 at 10:29 | Source: Moneycontrol.com
Sun Pharmaceutical Industries Ltd has informed BSE that the Company is in receipt of direction under Section 29(2) of the Competition Act, 2002 from CCI directing Sun Pharma to publish the details of the proposed combination within 10 working days from August 27, 2014 in Form IV contained in Schedule II to the Combination Regulations.
Aug 28, 2014 at 08:21 | Source: CNBC-TV18
Rural Electrification Corporation | Power Finance Corporation | ONGC | NHPC | Coal India | Adani Power | Tata Power | DLF | Piramal Enterprises | Navin Fluorine | Torrent Pharma | PNB | UCO Bank | Liberty Shoes | ITD Cementation | Muthoot Finance | Financial Tech | MCX India and Gayatri Projects are stocks, which are in the news today.
Aug 27, 2014 at 18:46 | Source: PTI
According to the regulator, pursuant to the rights issue, Sun Pharma Advanced Research Ltd had allotted 16.5 lakh partly paid-up shares to Virtuous Share Investments on October 3, 2012.
Aug 26, 2014 at 15:46 | Source: CNBC-TV18
Ashu Madan of Religare Securities advises holding Sun Pharmaceutical Industries.
Aug 26, 2014 at 15:25 | Source: Moneycontrol.com
According to a Quant report, most pharma companies continue to have strong ANDA filings pending for approval, which gives enough confidence of high long-term growth, subject to timely regulatory approval.
Aug 26, 2014 at 15:07 | Source: CNBC-TV18
Watch the interview of Nooresh Merani of Analyse India and Ashu Madan of Religare Securities with Sumaira Abidi & Nigel D'Souza on CNBC-TV18, in which they shared their reading and outlook on market and specific stocks.
Aug 25, 2014 at 16:01 | Source: Moneycontrol.com
The S&P Healthcare index is up nearly 32 percent this year, compared to 25 percent rally on the stock exchanges benchmark 30-share index Sensex.
Aug 25, 2014 at 12:44 | Source: Moneycontrol.com
Brokerage house Emkay Global Financial Services is bullish on Sun Pharmaceutical Industries and has recommended buy rating on the stock with a target price of Rs 928 in its August 13, 2014 research report.